ANEBULO PHARMAC INC ANEB
$0.32
+6.67%
at last close
Analyst Consensus
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-07-23 | Maxim GroupMichael Okunewitch |
Downgrades | Buy → Hold | — |
| 2025-05-15 | Maxim GroupMichael Okunewitch |
Maintains | Buy | $6 → $3 |
| 2024-11-19 | BenchmarkRobert Wasserman |
Reiterates | Speculative buy | $8 |
| 2024-10-01 | BenchmarkRobert Wasserman |
Reiterates | Speculative buy | $8 |
| 2023-10-03 | BenchmarkRobert Wasserman |
Reiterates | Speculative buy | $8 |
| 2023-09-25 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $6 |
| 2023-09-21 | Maxim GroupMichael Okunewitch |
Initiates coverage on | Buy | $6 |
| 2023-09-18 | HC Wainwright & Co.Raghuram Selvaraju |
Initiates coverage on | Buy | $6 |
| 2023-05-18 | BenchmarkRobert Wasserman |
Reiterates | Speculative buy | $8 |
| 2023-02-14 | BenchmarkRobert Wasserman |
Maintains | Speculative buy | $10 → $8 |
| 2022-07-27 | Ladenburg ThalmannAydin Huseynov |
Initiates coverage on | Buy | $6 |
| 2021-05-25 | BenchmarkRobert Wasserman |
Initiates coverage on | Buy | $15 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.32
- Market Cap
- —
- 52-Week Range
- $0.00 – $3.42
- Average Volume
- 381 shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.